Halozyme Therapeutics | HALO - Resultado Líquido

Preço das Ações
63.83
Mudança Diária
0.77 1.22%
Mensal
-1.24%
Anual
6.33%
Q2 Previsão
63.96




Resultado Líquido Alterar Data
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Agios Pharmaceuticals USD -99.11M 8.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Cara Therapeutics USD -5.53M 621K 2025-09
Cytokinetics USD -183.03M 123.15M 2025-12
DBV Technologies USD -33.16M 8.71M 2025-09
Eli Lilly USD 6.64B 1.05B 2025-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Halozyme Therapeutics USD -141.59M 316.82M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
MannKind USD -15.95M 23.93M 2025-12
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
United Therapeutics USD 364.3M 25.6M 2025-12
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12